About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
Biocon Quarterly Results
  > INVESTORS
  Overview
  Corporate Structure
  Corporate Governance
  Company History
  Annual General Meeting
  Investor FAQs
  Stock Info
  Financial Results
  Subsidiary Financials
  Annual Report
  Disclosure to Stock Exchange
  Press Releases
  Presentations
  Analyst Coverage
  Investor Contacts
  
  Home
  
     
 
Financials

Financial Results

 
 
  Consolidated Financial Performance (FY12-16)

All Figures in Rs. Crores except EPS 

Business Segment FY16 FY15 FY14 FY13 FY12
 Biopharmaceuticals

2391

2236 2138 1871 1676
   - Biopharma 1954 1807 1747 1523 1417
   - Branded
     Formulations
437 430 391 347 259
 Contract Research 1060 823 715 557 410
 Total Sales 3451 3059 2853 2423 2087
 Other Income 119 84 80 110 62
 Total Revenue 3570 3143 2933 2538 2148
 EBITDA 903 749 743 596 579
 EBITDA Margin (%) 25% 24% 25% 23% 27%
 Net Profit* 437 402 414 324 338
 Net Profit Margin 14% 13% 14% 13% 16%
 EPS 44.8 24.8 20.7 25.4 16.9
 R&D Spends
 (in P&L)
275 169 131 164 157
 R&D (as % of
 Biopharmaceuticals
 Sales)
11.5% 7.5% 6.1% 8.8% 9.3%

 *Net Profit is pre-exceptional

Current Financial Year 2016-17

  FY 16-17 Q1 H1 9M FY
Notice Ad Notice Ad Q1 FY 2016-17      
  Press Release Press Release Q1 FY 2016-17 - - -
  Fact Sheet - - -
  Transcript of the Call Transcript of Q1 FY17 - - -
Newspaper Advertisement - - -
  Results - - -
  Investor Presentation - - - -

Financial Highlights*

In Rs. Crore 
  FY 16-17 Q1 H1 9M FY
  Revenue 1031 - - -
  EBITDA 304 - - -
  Net Profit 167 - - -
  R&D Expenses in P&L 52 - - -
  Total R&D Spends 92 - - -
  EBITDA Margins 28% - - -
  Net Profit Margins 15% - - -
 
  * As per the new accounting standard: Ind-AS  
  FY16-17  FY15-16  FY14-15  FY13-14  FY12-13  FY11-12  FY10-11  FY09-10  FY08-09  FY07-08  FY06-07  FY05-06  FY04-05 

 
Quarterly Results
 
 
 
 
 
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer            © 2016, Biocon. All Rights Reserved